ETFs
G
GILD
Gilead Sciences Inc
150.11
-0.78-0.52%After Hours: 150.68 +0.57 +0.38%18:59 09/18 EDT
OPEN/PREV CLOSE150.56/150.89
TODAY RANGE149.57-153.23
VOL16.42M
MARKET CAP186.13B
52 WEEK RANGE105.84-154.51
AVG VOL (3M)6.76M
% TURNOVER0.55%
TURNOVER--
P/E (TTM)-56.5365
% RANGE2.43%
EPS(TTM)-2.6551
P/E(FORWARD)-45.4015
P/B15.75
BVPS9.53
DIVIDEND3.280
P/S6.33
BETA--
DIV YIELD2.19%
FREE FLOAT MKT CAP185.90B
SHARES OUTSTANDING1.24B
NEXT EARNINGS10/28-11/02
FREE FLOAT1.24B
LOT SIZE1
EX-DATE09/15/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
5 Undervalued Oncology Stocks Wall Street Is Overlooking
Dow Jones·3d ago
Moderna Inc. Stock Climbs 8.5%, Outperforms Peers
Seeking Alpha·3d ago
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
Simply Wall St·3d ago
Should Expanded HIV Access Require Action From Gilead (GILD) Investors?
Seeking Alpha·4d ago
Gilead expands voluntary licensing agreements for once-yearly Yeztugo
Simply Wall St·5d ago
Should Gilead Sciences (GILD) Reconsider Its Global HIV Case After This PAHO Deal?
TipRanks·5d ago
Gilead announces agreement with PAHO for lenacapavir access
Simply Wall St·09/13 02:16
Gilead (GILD) Stock Still Looks Cheap Despite New Research Center